Study of Safety and Efficacy of RVL-1201 in the Treatment of Blepharoptosis
Clinical trial NCT03565887 · COMPLETED
Trial details
- NCT number
- NCT03565887
- Sponsor
- RVL Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-28
- Primary completion
- 2019-04-11
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.